US Secretary of State Antony Blinken met the head of Israel’s Mossad spy agency and its ambassador to Washington on Thursday, and the Israeli officials expressed “deep concern” about Iran’s nuclear activities, the Reuters news agency reported, citing a person familiar with the matter.
The meeting in Washington followed talks this week between US National Security Adviser Jake Sullivan and his Israeli counterpart in which the Israeli delegation stressed their “freedom to operate” against Iran as they see fit, the source told Reuters, speaking on condition of anonymity.
As President Joe Biden explores a possible US return to the 2015 JCPOA deal to contain Iran’s nuclear programme that his predecessor Donald Trump abandoned, Israel has stepped up calls for more sweeping curbs to be imposed on sensitive Iranian technologies and projects.
Israel Ends Q1 With Increased State Revenue, But Experts Warn of Dangers Ahead themedialine.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themedialine.org Daily Mail and Mail on Sunday newspapers.
2 Min Read
FILE PHOTO: Vials labelled COVID-19 Coronavirus Vaccine and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration
JERUSALEM (Reuters) - Pfizer said on Monday it was working on a new deal to supply COVID-19 vaccines to Israel after an initial supply agreement forged in late 2020 has ended.
Pfizer and its partner BioNTech agreed in November to supply Israel with an undisclosed number of COVID-19 vaccines and Israel’s Finance Ministry has said it paid some 2.6 billion shekels ($785 million).
To date, 5.27 million Israelis above the age of 16 have received a first dose, while 4.84 million have received a second shot - out of a population of 9.3 million. Some Israelis have also received doses of Moderna’s vaccine, giving the country one of the highest inoculation rates in the world.